CTKB · Company research
Cytek Biosciences, Inc. Common Stock (CTKB): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableTechnology
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 5.34 | $741,808,768.14 | 667962768.14 | 271.5000000000000000 | — | — | 15.4094052376402160 | 2.3040830930505600 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.